Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2'- O -Methyltransferase (2'- O -MTase) Non-Structural Protein (Nsp10-16).

Autor: Benjamin MM; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA., Hanna GS; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA., Dickinson CF; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA., Choo YM; Department of Chemistry, University of Malaya, Kuala Lumpur 50603, Malaysia., Wang X; Department of Pharmacy, Lanzhou University, Lanzhou 730000, China., Downs-Bowen JA; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, HSRB-1, Atlanta, GA 30322, USA., De R; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, HSRB-1, Atlanta, GA 30322, USA., McBrayer TR; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, HSRB-1, Atlanta, GA 30322, USA., Schinazi RF; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, HSRB-1, Atlanta, GA 30322, USA., Nielson SE; Department of Chemistry & Biochemistry, Logan, UT 84322, USA., Hevel JM; Department of Chemistry & Biochemistry, Logan, UT 84322, USA., Pandey P; National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA., Doerksen RJ; Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, University of Mississippi, University, MS 38677, USA., Townsend DM; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President St, DD410, Charleston, SC 29425, USA., Zhang J; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President St, DD410, Charleston, SC 29425, USA., Ye Z; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President St, DD410, Charleston, SC 29425, USA., Wyer S; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA., Bialousow L; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA., Hamann MT; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA.; Department of Public Health Sciences, Medical University of South Carolina,135 Cannon St, Charleston, SC 29425, USA.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2024 Oct 28; Vol. 29 (21). Date of Electronic Publication: 2024 Oct 28.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial.

Autor: Wibrow B; Intensive Care Unit, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. bradley.wibrow@health.wa.gov.au.; Medical School, University of Western Australia, Perth, WA, Australia. bradley.wibrow@health.wa.gov.au., Martinez FE; Intensive Care Unit, John Hunter Hospital, Newcastle, NSW, Australia.; School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia., Myers E; Intensive Care Unit, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; School of Nursing, Midwifery, Health Sciences and Physiotherapy, Notre Dame University, Perth, WA, Australia., Chapman A; Intensive Care Unit, Royal Perth Hospital, Perth, WA, Australia., Litton E; Medical School, University of Western Australia, Perth, WA, Australia.; Intensive Care Unit, St John of God Hospital, Subiaco, WA, Australia., Ho KM; Medical School, University of Western Australia, Perth, WA, Australia.; Intensive Care Unit, Royal Perth Hospital, Perth, WA, Australia.; School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia., Regli A; Medical School, University of Western Australia, Perth, WA, Australia.; Intensive Care Unit, St John of God Murdoch Hospital, Murdoch, WA, Australia.; Medical School, The University of Notre Dame Australia, 19 Mouat Street, Fremantle, 6959, Australia., Hawkins D; Intensive Care Unit, Joondalup Health Campus, Joondalup, WA, Australia., Ford A; Medical School, University of Western Australia, Perth, WA, Australia.; Royal Perth Hospital, Perth, WA, Australia., van Haren FMP; Intensive Care Unit, St George Hospital, Sydney, Australia.; College of Health and Medicine, Australian National University, Canberra, Australia.; University of New South Wales Medicine and Health, Sydney, Australia., Wyer S; Intensive Care Unit, Gosford and Wyong Hospitals, Gosford, Australia., McCaffrey J; Intensive Care Unit, Barwon Health, Geelong, Australia., Rashid A; Intensive Care Unit, Mater Hospital, Newcastle, Australia., Kelty E; School of Population and Global Health, University of Western Australia, Perth, Australia., Murray K; School of Population and Global Health, University of Western Australia, Perth, Australia., Anstey M; Intensive Care Unit, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Medical School, University of Western Australia, Perth, WA, Australia.; School of Public Health, Curtin University, Perth, Australia.

Publikováno v: Intensive care medicine [Intensive Care Med] 2022 Apr; Vol. 48 (4), pp. 414-425. Date of Electronic Publication: 2022 Feb 27.

Predicting attendance at cardiac rehabilitation: a review and recommendations

Autor: Wyer, S., Joseph, S., Earll, L.

Publikováno v: In Coronary Health Care November 2001 5(4):171-177

Patients' Care Transition in Cardiac Rehabilitation: A Scoping Review on Facilitators and Challenges Related to Referral and Enrolment.

Autor: Ravn, Maiken Bay^1,2 (AUTHOR) mairav@rm.dk, Sevel, Claus Theilgaard³ (AUTHOR), Handberg, Charlotte^1,4 (AUTHOR), Pedersen, Charlotte Gjørup^1,5 (AUTHOR), Maribo, Thomas^1,2 (AUTHOR), Nielsen, Claus Vinther^1,2,6 (AUTHOR), Chen, Qing-Wei (AUTHOR)

Publikováno v: Health & Social Care in the Community. 8/20/2024, Vol. 2024, p1-13. 13p.